Moore Kuehn, PLLC Encourages Investors of Corcept Therapeutics, Inc. to Contact Law Firm

October 04, 2021 10:23 AM EDT | Source: Kuehn Law, PLLC

New York, New York--(Newsfile Corp. - October 4, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Corcept Therapeutics, Inc. (NASDAQ: CORT) breached their fiduciary duties to shareholders.

According to a federal securities lawsuit, Corcept insiders caused the company to make false and/or misleading statements and/or failed to disclose that: (1) that the company had improperly paid doctors to promote its drug Korlym; (2) that the company aggressively promoted Korlym for off-label uses; (3) that the company's sole specialty pharmacy was a related party; (4) that the company artificially inflated its revenue and sales using illicit sales practices through a related party; (5) that such practices are reasonably likely to lead to regulatory scrutiny; and (6) that, as a result of the foregoing, positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On August 24, 2021, U.S. District Court Judge Lucy H. Koh denied defendants' motion to dismiss the class action complaint, paving the way for litigation to proceed against Corcept and certain insider defendants.

If you currently own CORT and purchased prior to August 2, 2017 please contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. There is no cost to you. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers. Please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/98458

info